Larson Yi 4
4 · LianBio · Filed Dec 3, 2021
Insider Transaction Report
Form 4
LianBioLIAN
Larson Yi
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-01+5,996→ 1,202,841 totalExercise: $16.00Exp: 2031-12-01→ Ordinary Shares (5,996 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option shall vest and become exercisable on December 1, 2022; the remainder shall vest and become exercisable in three equal annual installments such that the option shall be fully vested on December 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.